Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy

被引:4
|
作者
Zhang, Hao [1 ]
Huo, Junyu [1 ]
Jiang, Wanying [1 ]
Shan, Qijun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
关键词
dilated cardiomyopathy; hub gene; gene expression omnibus; bioinformatics; ACUTE KIDNEY INJURY; HEART-FAILURE; INTERNATIONAL-SOCIETY; TASK-FORCE; PROENKEPHALIN; DYSFUNCTION; DOXORUBICIN; EXPRESSION; IDENTIFICATION; MANAGEMENT;
D O I
10.3892/mmr.2020.11145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dilated cardiomyopathy (DCM) is a primary cardiomyopathy with high mortality. The aim of the present study was to identify the related genes in DCM. The four expression profiles (GSE17800, GSE21610, GSE42955 and GSE79962) downloaded from the Gene Expression Omnibus (GEO) database were analyzed using RankProd and metaMA R packages to identify differentially expressed genes (DEGs). DEGs were uploaded to the Database for Annotation, Visualization and Integrated Discovery (DAVID), for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. A protein-protein interaction (PPI) network of the DEGs was constructed using the STRING database. In addition, hub genes were identified using the Cytoscape plugin cytoHubba. A mouse DCM model, which established via intraperitoneal injection with doxorubicin (DOX), was used to validate the hub genes. A total of 898 DEGs were identified across the four microarrays. Furthermore, GO analysis demonstrated that these DEGs were mainly enriched in cell adhesion, negative regulation of cell proliferation, negative regulation of apoptotic process and potassium ion transport. In addition, KEGG analysis revealed that DEGs were mainly enriched in the ECM-receptor interaction, the p53 signaling pathway, cardiac muscle contraction and the hypoxia-inducible factor signaling pathway. Proenkephalin (PENK), chordin like 1 (CHRDL1), calumenin (CALU), apolipoprotein L1, insulin-like growth factor binding protein 3 (IGFBP3) and ceruloplasmin (CP) were identified as hub genes in the PPI network. Furthermore, the expression levels of PENK, CHRDL1, IGFBP3, CP and CALU in hearts with DCM were validated using a mouse model. In conclusion, the present study identified six hub genes related to DCM. Therefore, the present results may provide a potential mechanism for DCM involving these hub genes, which may serve as biomarkers for screening and diagnosis in the clinic.
引用
收藏
页码:915 / 925
页数:11
相关论文
共 50 条
  • [41] Circulating Endothelial Progenitor Cells: Potential Biomarkers for Idiopathic Dilated Cardiomyopathy
    Roura, Santiago
    Galvez-Monton, Carolina
    Fernandez, Marco A.
    Lupon, Josep
    Bayes-Genis, Antoni
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2016, 9 (01) : 80 - 84
  • [42] Exploring novel biomarkers in dilated cardiomyopathy-induced heart failure by integrated analysis and in vitro experiments
    Zhou, Lei
    Peng, Fei
    Li, Juexing
    Gong, Hui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
  • [43] Using proteomics to identify potential therapeutic targets in platelets
    Maguire, FB
    Foy, M
    Fitzgerald, DJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 : 409 - 412
  • [44] Integration of Microarray CGH and Expression Analysis Reveals Potential Breast Cancer Therapeutic Targets
    Muggerud, A.
    Horlings, H.
    Lambros, M. B.
    Natrajan, R.
    Mackay, A.
    Ashworth, A.
    van de Vijver, M. J.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2010, 23 : 63A - 63A
  • [45] Integration of Microarray CGH and Expression Analysis Reveals Potential Breast Cancer Therapeutic Targets
    Muggerud, A.
    Horlings, H.
    Lambros, M. B.
    Natrajan, R.
    Mackay, A.
    Ashworth, A.
    van de Vijver, M. J.
    Reis-Filho, J. S.
    LABORATORY INVESTIGATION, 2010, 90 : 63A - 63A
  • [46] Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
    Sung, Miranda M.
    Hamza, Shereen M.
    Dyck, Jason R. B.
    ANTIOXIDANTS & REDOX SIGNALING, 2015, 22 (17) : 1606 - 1630
  • [47] Identification of potential therapeutic targets for plaque vulnerability based on an integrated analysis
    Miao, Liu
    Qin, Yue-Ai
    Yang, Zhi-Jie
    Shi, Wan-Xin
    Wei, Xin-Qiao
    Liu, Yuan
    Liu, Yan-Li
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (07) : 1649 - 1659
  • [48] Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy
    Huang, Kai
    Wen, Shuyan
    Huang, Jiechun
    Wang, Fangrui
    Pang, Liewen
    Wang, Yiqing
    Sun, Xiaotian
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [49] Investigating possible dilated cardiomyopathy targets via bioinformatic analysis
    Zhou, Jun
    Wang, Xueting
    Xiong, Weiping
    Zhang, Min
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (07): : 4788 - 4795
  • [50] Integrated genomics-based approach to identify new therapeutic targets and cancer biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)